Incyte Corporation - Common Stock (NQ:INCY)

90.30 -1.96 (-2.12%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 27, 2026 Add to My Watchlist

Price and Volume

Volume	1,494,297
Open	92.28
Bid (Size)	90.30 (200)
Ask (Size)	95.95 (100)
Prev. Close	92.26
Today's Range	90.20 - 92.50
52wk Range	53.56 - 112.29
Shares Outstanding	222,430,635
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Incyte Announces Executive Leadership Appointments

March 25, 2026

From Incyte

Via Business Wire

2 Growth Stocks with Explosive Upside and 1 We Avoid

March 23, 2026

Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va...

Via StockStory

Performance

YTD	-11.0%	-11.0%
1 Month	-10.6%	-10.6%
3 Month	-9.8%	-9.8%
6 Month	+10.6%	+10.6%
1 Year	+47.4%	+47.4%

More News

Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting

March 20, 2026

From Incyte

Via Business Wire

1 Cash-Heavy Stock to Target This Week and 2 Facing Headwinds

March 16, 2026

Via StockStory

Incyte Corp (NASDAQ:INCY) Presents a Compelling Value Case with Strong Fundamentals ↗

February 21, 2026

Via Chartmill

2 Value Stocks to Consider Right Now and 1 We Ignore

March 13, 2026

Via StockStory

Incyte (INCY): Buy, Sell, or Hold Post Q4 Earnings?

March 11, 2026

Via StockStory

Incyte’s Drug Approved In Europe For Treating Yet Another Rare Cancer ↗

March 06, 2026

Via Stocktwits

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)

March 06, 2026

From Incyte

Via Business Wire

1 Cash-Producing Stock with Exciting Potential and 2 We Avoid

March 04, 2026

Via StockStory

3 S&P 500 Stocks to Target This Week

February 23, 2026

Via StockStory

Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year ↗

February 23, 2026

Via The Motley Fool

This Fund Bet Nearly $40 Million on GRAIL Last Quarter. The Stock Just Plunged Over 50% ↗

February 23, 2026

Via The Motley Fool

February 18, 2026

Via StockStory

Registration Momentum Builds Across the Oncology Pipeline

February 17, 2026

From USA News Group

Via GlobeNewswire

Incyte to Present at Upcoming Investor Conferences

February 17, 2026

From Incyte

Via Business Wire

The Top 5 Analyst Questions From Incyte’s Q4 Earnings Call

February 17, 2026

Via StockStory

Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss

February 11, 2026

Via Finterra

INCY Q4 Deep Dive: Revenue Growth Outpaces Profit as Pipeline Advances, Margins Narrow

February 11, 2026

Via StockStory

What's going on in today's session: S&P500 movers ↗

February 10, 2026

Via Chartmill

Stay informed with the top movers within the S&P500 index on Tuesday. ↗

February 10, 2026

Via Chartmill

Why Incyte (INCY) Stock Is Nosediving

February 10, 2026

Via StockStory

Which S&P500 stocks are gapping on Tuesday? ↗

February 10, 2026

Via Chartmill

Incyte (INCY) Q4 2025 Earnings Call Transcript ↗

February 10, 2026

Via The Motley Fool

Which S&P500 stocks are moving before the opening bell on Tuesday? ↗

February 10, 2026

Via Chartmill

Frequently Asked Questions

Is Incyte Corporation - Common Stock publicly traded?

Yes, Incyte Corporation - Common Stock is publicly traded.

What exchange does Incyte Corporation - Common Stock trade on?

Incyte Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Incyte Corporation - Common Stock?

The ticker symbol for Incyte Corporation - Common Stock is INCY on the Nasdaq Stock Market

What is the current price of Incyte Corporation - Common Stock?

The current price of Incyte Corporation - Common Stock is 90.30

When was Incyte Corporation - Common Stock last traded?

The last trade of Incyte Corporation - Common Stock was at 03/27/26 04:00 PM ET

What is the market capitalization of Incyte Corporation - Common Stock?

The market capitalization of Incyte Corporation - Common Stock is 20.09B

How many shares of Incyte Corporation - Common Stock are outstanding?

Incyte Corporation - Common Stock has 20B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.